참고문헌
- ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update 2009; 15: 265-77. https://doi.org/10.1093/humupd/dmp003
- Kolibianakis EM, Devroey P. The luteal phase after ovarian stimulation. Reprod Biomed Online 2002; 5(Suppl 1): 26-35.
- Pabuccu R, Akar ME. Luteal phase support in assisted reproductive technology. Curr Opin Obstet Gynecol 2005; 17: 277-81. https://doi.org/10.1097/01.gco.0000169105.62257.e3
- Practice Committee of the American Society for Reproductive Medicine. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin. Fertil Steril 2008; 89: 789-92. https://doi.org/10.1016/j.fertnstert.2008.02.012
- Erdem A, Erdem M, Atmaca S, Guler I. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study. Fertil Steril 2009; 91: 2508-13. https://doi.org/10.1016/j.fertnstert.2008.04.029
- Hubayter ZR, Muasher SJ. Luteal supplementation in in vitro fertilization: more questions than answers. Fertil Steril 2008; 89: 749-58. https://doi.org/10.1016/j.fertnstert.2008.02.095
- Pouly JL, Bassil S, Frydman R, Hedon B, Nicollet B, Prada Y, et al. Luteal support after in-vitro fertilization: crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Hum Reprod 1996; 11: 2085-9. https://doi.org/10.1093/oxfordjournals.humrep.a019054
- Friedler S, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14: 1944-8. https://doi.org/10.1093/humrep/14.8.1944
- Licciardi FL, Kwiatkowski A, Noyes NL, Berkeley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril 1999; 71: 614-8. https://doi.org/10.1016/S0015-0282(98)00515-9
- Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins. Maturitas 2003; 46(Suppl 1): S7-16.
- Gruber CJ, Huber JC. The role of dydrogesterone in recurrent (habitual) abortion. J Steroid Biochem Mol Biol 2005; 97: 426-30. https://doi.org/10.1016/j.jsbmb.2005.08.009
- Szekeres-Bartho J, Balasch J. Progestagen therapy for recurrent miscarriage. Hum Reprod Update 2008; 14: 27-35.
- Queisser-Luft A. Dydrogesterone use during pregnancy: overview of birth defects reported since 1977. Early Hum Dev 2009; 85: 375-7. https://doi.org/10.1016/j.earlhumdev.2008.12.016
- Patki A, Pawar VC. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecol Endocrinol 2007; 23(Suppl 1): 68-72. https://doi.org/10.1080/09513590701584857
- Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol 2005; 97: 416-20. https://doi.org/10.1016/j.jsbmb.2005.08.012
- Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril 2006; 85: 1774-7. https://doi.org/10.1016/j.fertnstert.2006.02.070
- Penzias AS. Luteal phase support. Fertil Steril 2002; 77: 318-23. https://doi.org/10.1016/S0015-0282(01)02961-2
- Domitrz J, Wolczynski S, Syrewicz M, Szamatowicz J, Kuczynski W, Grochowski D, et al. The comparison of efficiency of supplement of the second phase in the program IVF-ET by dydrogesterone and progesterone. Ginekol Pol 1999; 70: 8-12.
- Tavaniotou A, Smitz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 2000; 6: 139-48. https://doi.org/10.1093/humupd/6.2.139